Riskpilot← Back to searchSign inGet full accessNya MedicaNatumin AB
ABActiveOrg 5593702797Ingmar Bergmans Gata 2Business and other management consultancy activities · NACE 7020Est. 20220 employees
Revenue 2024
SEK 0
EBITDA margin
—
+82% vs 2023
Equity ratio
73.0%
Financial strength
Net profit 2024
SEK -695K
-248% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -29K | +82% |
| Net profit | SEK -695K | -248% |
| Total assets | SEK 116,8M | +0% |
| Equity | SEK 85,2M | -1% |
| Employees | 0 | — |
Legal name
Nya MedicaNatumin AB
Org number
5593702797
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
14 mars 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet ska vara att bedriva handel med kosttillskott, naturmedel, läkemedel, medicinteknisk utrustning och kosmetik, förvalta värdepapper, samt bedriva annan därmed förenlig verksamhet.
Address
Ingmar Bergmans Gata 2
Email
info@humblegroup.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 1 526 | 1 526 415 | 32 | 0 |
| Staff expenses | — | −124 562 | — | — |
| EBITDA | 956 | 956 027 | −158 | −29 |
| Depreciation & amort. | −317 | −317 365 | −0 | −0 |
| EBIT | 639 | 638 662 | −158 | −29 |
| Net financials | −904 | −904 | −317 | −666 |
| Profit before tax | −266 | −266 | 740 | −695 |
| Tax | −0 | −0 | −269 | −0 |
| Net profit | −266 | −266 | 471 | −695 |
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 117 590 | 117 590 415 | 117 102 | 116 778 |
| Equity | 85 469 | 85 469 | 85 939 | 85 244 |
| Long-term debt | 6 377 | 6 376 584 | 6 693 | 7 354 |
| Short-term debt | 25 745 | 25 745 279 | 24 469 | 24 180 |
| Total debt | 32 122 | 32 122 | 31 162 | 31 534 |
EBITDA margin
-2900000.0%
This company
15.8%
Market median
-18354530% vs market
20222024
Equity ratio
73.0%
This company
38.2%
Market median
+91% vs market
20222024
Return on equity
-0.8%
This company
18.4%
Market median
-104% vs market
20222024
Net profit margin
-69500000.0%
This company
8.1%
Market median
-858024791% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-03-14 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-03-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SC Chief Auditor | Chief Auditor | 2023 |
| Former (2) | ||
BC Chief Auditor | Chief Auditor | 2022 – 2023 |
JP Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2025 | |
| Board of Directors | 2022 | |
| Former (7) | ||
| Deputy Board Member | 2022 – 2022 | |
| Chairman | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Chairman | 2022 – 2022 | |
| Chairman | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Humble Group AB
Nya MedicaNatumin AB Board members of Nya MedicaNatumin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sandra Clara Ellen Hvitman | Chief Auditor | 0 companies |
| Bengt Claes Joakim Falck | Chief Auditor | 0 companies |
| Jan Peter Hencz | Chief Executive Officer | 0 companies |
| Lars Magnus Kärnerud | Deputy Board Member | 0 companies |
| M H Charlotte Wiberg Larsson | Chairman | 0 companies |
| Bo Torsten Nilsson | Board of Directors | 0 companies |
| Jonas Carpvik | Chairman | 0 companies |
| Noel Christofer Peter Abdayem | Board of Directors | 0 companies |
| Simon Gustav Seved Petrén | Chairman | 0 companies |
| Marcus Erik Johan Stenkil | Chairman | 0 companies |
| Peter Jonas Michael Carlborg | Deputy Board Member | 0 companies |
| Johan Christer Lennartsson | Board of Directors | 0 companies |
| Bo Torsten Patrik Nilsson | Deputy Board Member | 0 companies |